Horm Metab Res 2013; 45(05): 372-377
DOI: 10.1055/s-0032-1331744
Original Basic
© Georg Thieme Verlag KG Stuttgart · New York

Peptides Binding to the Hunger Hormone Ghrelin

M. Vodnik
1   Department of Pharmaceutical Biology, Faculty of Pharmacy, Ljubljana, Slovenia
,
P. Molek
1   Department of Pharmaceutical Biology, Faculty of Pharmacy, Ljubljana, Slovenia
,
B. Štrukelj
1   Department of Pharmaceutical Biology, Faculty of Pharmacy, Ljubljana, Slovenia
2   Department of Biotechnology, Jozef Stefan Institute, Slovenia
,
M. Lunder
1   Department of Pharmaceutical Biology, Faculty of Pharmacy, Ljubljana, Slovenia
› Author Affiliations
Further Information

Publication History

received 31 July 2012

accepted 29 November 2012

Publication Date:
11 January 2013 (online)

Abstract

The neutralisation of circulating ghrelin, the only known peripheral orexigenic peptide hormone, is a promising approach for the pharmacological treatment of obesity. To select peptides with an affinity towards ghrelin, 4 selection procedures were carried out with random peptide phage display libraries Ph.D.-7 and Ph.D.-12. Due to the absence of a common consensus motif, a stepwise elimination approach was used. The pool of selected peptides displaying phage clones was thoroughly examined to remove any potential target-unrelated peptides. The affinity of the remaining phage clones for ghrelin was tested with ELISA. An analysis of the binding properties revealed four-phage displayed peptides that bind to ghrelin with moderate affinity, with ADTVPRH and MEMKKTHPVLGA being the most specific. Additional advantage of peptide MEMKKTHPVLGA is an indication of binding to octanoyl group on N-terminal part of ghrelin, involved in receptor interaction. Hence peptide MEMKKTHPVLGA represents the most suitable lead for further investigation.

 
  • References

  • 1 Hosoda H, Kojima M, Kangawa K. Biological, physiological, and pharmacological aspects of ghrelin. J Pharmacol Sci 2006; 100: 398-410
  • 2 Hosoda H, Kojima M, Mizushima T, Shimizu S, Kangawa K. Structural divergence of human ghrelin. J Biol Chem 2003; 278: 64-70
  • 3 Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone. Cell 2008; 132: 387-396
  • 4 Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman MD, Jin Z, Witcher DR, Luo S, Onyia JE, Hale JE. Ghrelin octanoylation mediated by an orphan lipid transferase. Proc Natl Acad Sci USA 2008; 105: 6320-6325
  • 5 Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone releasing acylated peptide from stomach. Nature 1999; 402: 656-660
  • 6 Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes 2001; 50: 1714-1719
  • 7 Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin E, Heiman ML. Circulating ghrelin levels are decreased in human obesity. Diabetes 2001; 50: 707-709
  • 8 Schmid DA, Held K, Ising M, Uhr M, Weikel JC, Steiger A. Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls. Neuropsychopharmacol 2005; 30: 1187-1192
  • 9 Druce MR, Neary NM, Small CJ, Milton J, Monteiro M, Patterson M, Ghatei MA, Bloom SR. Subcutaneous administration of ghrelin stimulates energy intake in healthy lean human volunteers. Int J Obesity 2006; 30: 293-296
  • 10 Müller TD, Perez-Tilve D, Tong J, Pfluger PT, Tschöp MH. Ghrelin and its potential in the treatment of eating/wasting disorders and cachexia. J Cachexia Sarcopenia Muscle 2010; 1: 159-167
  • 11 Zorrilla EP, Iwasaki S, Moss JA, Chang J, Otsuji J, Inoue K, Meijler MM, Janda KD. Vaccination against weight gain. Proc Natl Acad Sci 2006; 103: 13226-13231
  • 12 Vizcarra JA, Kirby JD, Kimb SK, Galyean ML. Active immunization against ghrelin decreases weight gain and alters plasma concentrations of growth hormone in growing pigs. Domest Anim Endocrin 2007; 33: 176-189
  • 13 Zakhari JS, Zorrilla EP, Zhou B, Mayorov AV, Janda KD. Oligoclonal antibody targeting ghrelin increases energy expenditure and reduces food intake in fasted mice. Mol Pharmaceutics 2012; 9: 281-289
  • 14 Lu S, Xu J, Chinookoswong N, Liu S, Steavenson S, Gegg C, Brankow D, Lindberg R, Véniant M, Gu W. An acyl-ghrelin-specific neutralizing antibody inhibits the acute ghrelin-mediated orexigenic effects in mice. Mol Pharmacol 2009; 75: 901-907
  • 15 Helmling S, Maasch C, Eulberg D, Buchner K, Schröder W, Lange C, Vonhoff S, Wlotzka B, Tschöp MH, Rosewicz S, Klussmann S. Inhibition of ghrelin action in vitro and in vivo by an RNA-Spiegelmer. Proc Natl Acad Sci USA 2004; 101: 13174-13179
  • 16 Huang J, Ru B, Zhu P, Nie F, Yang J, Wang X, Dai P, Lin H, Guo FB, Rao N. MimoDB 2.0: a mimotope database and beyond. Nucleic Acids Res 2012; 40: D271-D277
  • 17 Barbas III CF, Burton DR, Scott JK, Silverman GJ. General Phage Methods. In: Phage Display: A Laboratory Manual. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press; 2001: 17.22-17.24
  • 18 Vodnik M, Žager U, Štrukelj B, Lunder M. Phage display: selecting straws instead of a needle from a haystack. Molecules 2011; 16: 790-817
  • 19 Staes E, Absil PA, Lins L, Brasseur R, Deleu M, Lecouturier N, Fievez V, Rieux A, Mingeot-Leclercq MP, Raussens V, Préat V. Acylated and unacylated ghrelin binding to membranes and to ghrelin receptor: towards a better understanding of the underlying mechanisms. Biochim Biophys Acta 2010; 1798: 2102-2113